cjc-1295 no dac synergy with ipamorelin (No DAC) + – Pacific Edge Labs LLC CJC-1295 No DAC (10mg) +

This enhanced peptide variant delivers targeted benefits that can significantly improve quality of life and physical capabilities

Skin and IGF-1 lab improvements typically settle in over 3 to 6 months of consistent therapy

This explains why some patients experience: Temporary bloating or joint discomfort from fluid shifts Increased hunger due to ghrelin pathway activation Changes in blood sugar regulation in susceptible individuals Patients with diabetes, insulin resistance, or other metabolic conditions require medical evaluation and appropriate monitoring before and during treatment

Prefer to talk

Keep your fingers off the plunger

thanks grant support from the US National Institute of Health and American Heart Association